APYX Apyx Medical Corporation - Common Stock
NASDAQ · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$2,55
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$2,3252-Wochen-Tief
$5,0852-Wochen-Hoch
Marktkapitalisierung (MRQ)
$107M
P/E
-4.5
EPS
$-0.54
Umsatz
$53M
Ihre Abzeichen
52W-Spanne
$2–$5
Analystenbewertung
BUY
Kursziel
$7
P/E
-4.5
ROE
-78.0%
Nettogewinnmarge
-14.8%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
APYX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.55
Marktkapitalisierung (MRQ)
$107M
P/E
-4.5
EPS
$-0.54
Umsatz
$53M
ROE
-78.0%
Verschuldungsgrad (MRQ)
3.3
52W-Spanne
$2–$5
APYX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$53M2018-12-31 → 2025-12-31
EPS$-0.542018-12-31 → 2023-12-31
Freier Cashflow$-9M2018-12-31 → 2025-12-31
Nettogewinnmarge-14.8%2018-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | APYX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -4.55-Jahres-Durchschnitt ≈-9.3 | ≈-9.3 | · | · | |
| P/S (TTM) | 1.85-Jahres-Durchschnitt ≈3.3 | ≈3.3 | 3.6 | Fairer Wert | |
| K/B (MRQ) | 10.15-Jahres-Durchschnitt ≈5.6 | ≈5.6 | 3.5 | Überbewertet | |
| EV / EBITDA | -18.95-Jahres-Durchschnitt ≈-11.3 | ≈-11.3 | · | · | |
| Kurs / FCF (TTM) | -9.75-Jahres-Durchschnitt ≈-15.6 | ≈-15.6 | · | · | |
| Kurs / Cashflow (TTM) | -10.65-Jahres-Durchschnitt ≈-17.0 | ≈-17.0 | · | · | |
| EV / Revenue (EV / Umsatz) | 2.15-Jahres-Durchschnitt ≈1.9 | ≈1.9 | · | · | |
| EV / FCF | -12.05-Jahres-Durchschnitt ≈-11.2 | ≈-11.2 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 7.35-Jahres-Durchschnitt ≈5.6 | ≈5.6 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | APYX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 63.5%5-Jahres-Durchschnitt ≈64.6% | ≈64.6% | 46.2% | Spitzenklasse | |
| Betriebsgewinnmarge (TTM) | -6.1%5-Jahres-Durchschnitt ≈-33.4% | ≈-33.4% | -5.4% | Schwach | |
| EBITDA-Marge (TTM) | -4.7%5-Jahres-Durchschnitt ≈-31.9% | ≈-31.9% | -5.4% | Schwach | |
| Vorgewinnmarge (TTM) | -13.6%5-Jahres-Durchschnitt ≈-38.3% | ≈-38.3% | -4.2% | Schwach | |
| Nettogewinnmarge (TTM) | -14.8%5-Jahres-Durchschnitt ≈-37.8% | ≈-37.8% | -4.0% | Schwach | |
| ROA | -17.0%5-Jahres-Durchschnitt ≈-27.6% | ≈-27.6% | -38.2% | Spitzenklasse | |
| ROE | -78.0%5-Jahres-Durchschnitt ≈-65.5% | ≈-65.5% | 0.73% | Schwach | |
| ROIC | -13.4%5-Jahres-Durchschnitt ≈-34.0% | ≈-34.0% | -14.3% | Im Einklang |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | APYX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 3.35-Jahres-Durchschnitt ≈2.0 | ≈2.0 | 0.6 | Hohe Verschuldung | |
| Liquiditätsgrad (MRQ) | 5.75-Jahres-Durchschnitt ≈4.8 | ≈4.8 | 2.6 | Starke Liquidität | |
| Quick Ratio | 4.15-Jahres-Durchschnitt ≈3.6 | ≈3.6 | 1.5 | Starke Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | 3.35-Jahres-Durchschnitt ≈2.0 | ≈2.0 | 0.4 | Hohe Verschuldung |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | APYX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 9.9%5-Jahres-Durchschnitt ≈17.2% | ≈17.2% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 5.9%5-Jahres-Durchschnitt ≈9.7% | ≈9.7% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 13.8% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | APYX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.85-Jahres-Durchschnitt ≈0.7 | ≈0.7 | 0.7 | Spitzenklasse | |
| Inventory Turnover (Lagerumschlag) | 2.45-Jahres-Durchschnitt ≈2.1 | ≈2.1 | 2.4 | Im Einklang | |
| Receivables Turnover (Forderungsumschlag) | 3.35-Jahres-Durchschnitt ≈3.8 | ≈3.8 | 6.0 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$257.8K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
31.6%
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 6, 2026 | $-0.07 | $-0.08 | 16.3% |
| 31. März 2026 | $-0.05 | $-0.11 | 53.7% | |
| 31. Dezember 2025 | $-0.03 | $-0.06 | 48.6% | |
| 30. September 2025 | $-0.05 | $-0.10 | 52.2% | |
| 30. Juni 2025 | $-0.09 | $-0.10 | 5.5% | |
| 31. März 2025 | $-0.10 | $-0.12 | 18.3% | |
| 31. Dezember 2024 | $-0.12 | $-0.16 | 26.5% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $53M | $48M | $52M | $45M | $49M | $28M | $28M | $17M | $10M | $9M | $30M | $28M | |
| Cost of Revenue | $20M | $19M | $19M | $15M | $15M | $10M | $9M | $6M | $3M | $4M | $17M | $19M | |
| Gross Profit | $33M | $29M | $34M | $29M | $34M | $18M | $19M | $11M | $7M | $5M | $13M | $9M | |
| R&D Expense | $3M | $5M | $5M | $5M | $4M | $4M | $4M | $3M | $2M | $1M | $2M | $1M | |
| SG&A Expense | $16M | $19M | $22M | $20M | $19M | $12M | $14M | $9M | $9M | $6M | $8M | $7M | |
| Operating Expenses | $39M | $48M | $54M | $53M | $48M | $38M | $40M | $25M | $21M | $17M | $20M | $15M | |
| Operating Income | $-6M | $-19M | $-17M | $-24M | $-14M | $-20M | $-21M | $-14M | $-14M | $-11M | $-7M | $-6M | |
| Interest Expense | · | · | $2M | $15.0K | $10.0K | $46.0K | $8.0K | $104.0K | $136.0K | $158.0K | · | · | |
| Interest Income | $1M | $2M | $921.0K | $157.0K | $11.0K | $241.0K | $1M | $616.0K | $0 | $0 | · | · | |
| Other Non-op | $-4M | $-4M | $622.0K | $651.0K | $-372.0K | $674.0K | $1M | $-415.0K | $47.0K | $-94.0K | $2M | $-7M | |
| Pretax Income | $-11M | $-23M | $-21M | $-23M | $-15M | $-19M | $-20M | $-15M | $-14M | $-11M | $-5M | $-13M | |
| Income Tax | $270.0K | $252.0K | $-2M | $367.0K | $380.0K | $-8M | $-130.0K | $-4M | $-156.0K | $64.0K | $25.0K | $4M | |
| Net Income | $-11M | $-23M | $-19M | $-23M | $-15M | $-12M | $-20M | $63M | $-5M | $-12M | $-5M | $-17M | |
| EPS (Basic) | $-0.27 | $-0.66 | $-0.54 | $-0.67 | $-0.44 | $-0.35 | $-0.58 | $1.89 | $-0.16 | $-0.14 | $0.34 | $-1.03 | |
| EPS (Diluted) | · | · | $-0.54 | $-0.67 | $-0.44 | $-0.35 | $-0.58 | $1.83 | $-0.17 | $-0.15 | $0.24 | $-1.03 | |
| Shares (Basic) | 41,095,000 | 35,542,000 | 34,622,000 | 34,516,000 | 34,332,000 | 34,212,000 | 34,069,000 | 33,185,000 | 31,420,000 | 27,433,000 | 24,333,000 | 17,756,000 | |
| Shares (Diluted) | · | · | 34,622,000 | 34,516,000 | 34,332,000 | 34,212,000 | 34,069,000 | 34,366,000 | 31,427,000 | 27,449,000 | 27,747,000 | 17,756,000 | |
| EBITDA | $-6M | $-18M | $-17M | $-23M | $-14M | $-19M | $-20M | $-13M | $-5M | $-3M | · | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $32M | $32M | $44M | $10M | $31M | $42M | $59M | $17M | $10M | $14M | $12M | $6M | |
| Short-term Investments | · | · | · | · | · | $40M | $57M | $62M | $0 | · | · | · | |
| Receivables | $17M | $15M | $14M | $11M | $13M | $8M | $8M | $5M | $5M | $5M | $3M | $2M | |
| Inventory | $9M | $8M | $10M | $12M | $7M | $4M | $5M | $5M | $4M | $6M | $6M | $6M | |
| Prepaid Expense | $1M | $2M | $3M | $3M | $2M | $3M | $3M | $1M | $433.0K | $413.0K | $516.0K | $804.0K | |
| Current Assets | $58M | $56M | $70M | $43M | $61M | $66M | $77M | $90M | $23M | $27M | $22M | $15M | |
| PP&E (Net) | $2M | $2M | $2M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $7M | $7M | |
| PP&E (Gross) | $7M | $5M | $5M | $11M | $11M | $11M | $11M | $12M | $12M | $14M | $14M | $13M | |
| Accum. Depreciation | $4M | $4M | $4M | $5M | $5M | $5M | $4M | $6M | $6M | $7M | $7M | $-6M | |
| Goodwill | · | · | · | · | · | · | · | $185.0K | $185.0K | $185.0K | $185.0K | · | |
| Intangibles | · | · | · | · | · | · | · | $191.0K | $67.0K | $215.0K | $323.0K | $431.0K | |
| Other Non-current Assets | $2M | $2M | $2M | $1M | $1M | $807.0K | $391.0K | $41.0K | $67.0K | $103.0K | $430.0K | $415.0K | |
| Total Assets | $67M | $65M | $79M | $52M | $69M | $74M | $85M | $96M | $31M | $35M | $31M | $25M | |
| Accounts Payable | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $2M | $2M | $1M | $2M | |
| Accrued Liabilities | $8M | $8M | $10M | $9M | $10M | $7M | $9M | $6M | $214.0K | $3M | $2M | $2M | |
| Current Liabilities | $12M | $11M | $13M | $12M | $13M | $9M | $12M | $9M | $6M | $5M | $4M | $4M | |
| Capital Leases | $4M | $4M | $5M | $470.0K | $0 | $129.0K | $235.0K | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | $0 | $368.0K | $564.0K | $564.0K | · | |
| Other Non-current Liabilities | $347.0K | $259.0K | $198.0K | $181.0K | $166.0K | $166.0K | $114.0K | $0 | $100.0K | · | · | · | |
| Total Liabilities | $52M | $51M | $52M | $14M | $15M | $10M | $13M | $9M | $9M | $9M | $8M | $20M | |
| Long-term Debt | $38M | $38M | · | $0 | · | · | · | $0 | $3M | $3M | $140.0K | · | |
| Total Debt | $35M | $34M | $33M | · | · | · | · | $0 | $3M | $3M | · | · | |
| Common Stock | $42.0K | $38.0K | $35.0K | $35.0K | $34.0K | $34.0K | $34.0K | $34.0K | $33.0K | $31.0K | $27.0K | $18.0K | |
| Paid-in Capital | $104M | $92M | $81M | $73M | $66M | $61M | $57M | $53M | $50M | $50M | $43M | $29M | |
| Retained Earnings | $-89M | $-78M | $-54M | $-36M | $-13M | $3M | $15M | $34M | $-28M | $-23M | $-19M | $-28M | |
| Stockholders' Equity | $15M | $14M | $27M | $38M | $54M | $64M | $71M | $87M | $22M | $26M | $23M | $2M | |
| Liabilities + Equity | $67M | $65M | $79M | $52M | $69M | $74M | $85M | $96M | $31M | $35M | $31M | $25M | |
| Shares Outstanding | 41,785,946 | 37,793,886 | 34,643,888 | 34,597,822 | 34,409,912 | 34,289,222 | 34,169,952 | 33,704,525 | 32,878,091 | 30,859,753 | 27,051,172 | 17,852,330 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $655.0K | $599.0K | $692.0K | $890.0K | $903.0K | $887.0K | $754.0K | $669.0K | $696.0K | $734.0K | $812.0K | $876.0K | |
| Stock-based Comp | $2M | $4M | $5M | $7M | $5M | $4M | $4M | $2M | $871.0K | $809.0K | $575.0K | $388.0K | |
| Deferred Tax | · | $-4M | $-4M | $-5M | $-3M | $-1M | $-5M | $-164.0K | $1M | $-3M | $-25.0K | $4M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | |
| Other Non-cash | $554.0K | $5M | $12M | $417.0K | $2M | $-8M | $2M | $-14M | $-13.0K | $-455.0K | · | · | |
| Operating Cash Flow | $-8M | $-18M | $-5M | $-20M | $-10M | $-16M | $-18M | $-21M | $-4M | $-3M | $-6M | $-417.0K | |
| CapEx | $1M | $722.0K | $533.0K | $1M | $723.0K | $581.0K | $1M | $363.0K | $624.0K | $286.0K | $421.0K | $630.0K | |
| Investing Cash Flow | $-1M | $-722.0K | $7M | $-1M | $-723.0K | $-581.0K | $61M | $29M | $-624.0K | $-286.0K | $-921.0K | $-630.0K | |
| Debt Issued | · | $0 | $43M | $0 | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | $0 | $43M | · | · | · | $0 | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $0 | $0 | $6M | $12M | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | $0 | $0 | $6M | · | · | |
| Financing Cash Flow | $10M | $7M | $32M | $217.0K | $24.0K | $-73.0K | $147.0K | $-2M | $-239.0K | $6M | $13M | $-1M | |
| Net Change in Cash | $-1.0K | $-12M | $33M | $-21M | $-11M | $-17M | $42M | $6M | $-5M | $3M | $6M | $-2M | |
| Taxes Paid | $258.0K | $382.0K | $329.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-9M | $-19M | $-6M | $-21M | $-11M | $-17M | $-20M | $-21M | $-4M | $-3M | · | · | |
| Levered FCF | · | · | $-8M | $-21M | $-11M | $-17M | $-20M | $-21M | · | · | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 62.5% | 61.0% | 64.5% | 65.5% | 69.3% | 63.2% | 67.6% | 64.7% | 50.8% | 48.9% | · | · | |
| Operating Margin | -12.2% | -39.2% | -33.0% | -52.9% | -29.8% | -72.5% | -73.9% | -81.5% | -13.5% | -10.3% | · | · | |
| Net Margin | -21.2% | -48.8% | -35.8% | -52.1% | -31.3% | -42.9% | -69.8% | -56.9% | -13.0% | -10.8% | · | · | |
| Pretax Margin | -20.5% | -48.4% | -40.6% | -51.5% | -30.6% | -70.0% | -70.2% | -79.5% | -13.4% | -10.6% | · | · | |
| EBITDA Margin | -11.0% | -37.9% | -31.6% | -50.9% | -27.9% | -69.3% | -71.2% | -77.5% | -11.8% | -8.3% | · | · | |
| ROA | -17.0% | -32.6% | -28.6% | -38.5% | -21.2% | -15.0% | -22.3% | -9.1% | -15.3% | -11.9% | · | · | |
| ROE | -78.0% | -114.7% | -58.2% | -50.8% | -25.8% | -17.7% | -26.2% | -10.7% | -22.7% | -16.9% | · | · | |
| ROIC | -13.4% | -39.6% | -25.5% | -63.7% | -27.6% | -19.3% | -29.1% | -11.1% | -20.7% | -13.2% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 5.3 | 5.5 | 3.6 | 4.6 | 7.2 | 6.2 | 11.6 | 3.8 | 5.0 | · | · | |
| Quick Ratio | 4.1 | 4.4 | 4.5 | 1.8 | 3.3 | 9.8 | 5.4 | 10.8 | 2.5 | 3.6 | · | · | |
| Debt / Equity | 2.4 | 2.4 | 1.2 | · | · | · | · | 0.0 | 0.1 | 0.1 | · | · | |
| LT Debt / Equity | 2.4 | 2.4 | 1.2 | · | · | · | · | 0.0 | 0.1 | 0.1 | · | · | |
| Interest Coverage | · | · | -7.0 | -1570.8 | -1444.8 | -436.6 | -2608.6 | -130.8 | · | · | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.8 | 0.7 | 0.7 | 0.3 | 0.3 | 0.2 | 1.2 | 1.1 | · | · | |
| Inventory Turnover | 2.4 | 2.1 | 1.7 | 1.7 | 2.8 | 2.2 | 2.3 | 1.0 | 3.0 | 3.1 | · | · | |
| Receivables Turnover | 3.3 | 3.3 | 4.3 | 3.8 | 4.5 | 3.4 | 4.3 | 3.6 | 8.1 | 9.6 | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.35 | $0.38 | $0.77 | $1.09 | $1.56 | $1.86 | $2.09 | $2.60 | $0.67 | $0.85 | · | · | |
| Revenue / Share | · | · | $1.51 | $1.29 | $1.41 | · | $0.83 | $0.49 | $1.24 | $1.33 | · | · | |
| Cash Flow / Share | · | · | $-0.15 | $-0.59 | $-0.30 | · | $-0.54 | $-0.61 | $-0.12 | $-0.10 | · | · | |
| Cash / Share | $0.76 | $0.84 | $1.26 | $0.29 | $0.90 | $1.22 | $1.72 | $0.49 | $0.30 | $0.47 | · | · | |
| EPS (TTM) | $-0.57 | $-0.57 | $-0.54 | $-0.67 | $-0.44 | $-0.35 | $-0.58 | $1.83 | $-0.17 | $-0.15 | $0.24 | $-1.03 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.9% | -8.1% | 17.6% | -8.3% | 75.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.9% | -0.29% | 23.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 13.8% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $53M | $48M | $52M | $45M | $49M | $28M | $28M | $17M | $10M | $9M | $30M | $28M | |
| Net Income TTM | $-11M | $-23M | $-19M | $-23M | $-15M | $-12M | $-20M | $63M | $-5M | $-12M | $-5M | $-17M | |
| Market Cap | $146M | $60M | $91M | $81M | $441M | $247M | $289M | · | · | · | · | · | |
| Enterprise Value | $149M | $62M | $80M | · | · | · | · | · | · | · | · | · | |
| P/E | -6.1 | -2.8 | -4.9 | -3.5 | -29.1 | -20.6 | -14.6 | · | · | · | · | · | |
| P/S | 2.8 | 1.2 | 1.7 | 1.8 | 9.1 | 8.9 | 10.2 | · | · | · | · | · | |
| P/B | 10.1 | 4.2 | 3.4 | 2.2 | 8.2 | 3.9 | 4.1 | · | · | · | · | · | |
| P / Tangible Book | 10.1 | 4.2 | 3.4 | 2.2 | 8.2 | 3.9 | · | · | · | · | · | · | |
| P / Cash Flow | -18.3 | -3.3 | -17.3 | -4.0 | -42.2 | -15.4 | -15.6 | · | · | · | · | · | |
| P / FCF | -16.0 | -3.2 | -15.7 | -3.8 | -39.5 | -14.8 | -14.6 | · | · | · | · | · | |
| EV / EBITDA | -25.8 | -3.4 | -4.8 | · | · | · | · | · | · | · | · | · | |
| EV / FCF | -16.4 | -3.3 | -13.9 | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 2.8 | 1.3 | 1.5 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -16.3% | -36.1% | -20.6% | -28.6% | -3.4% | -4.9% | -6.9% | · | · | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14M | $12M | $19M | $13M | $11M | $9M | $14M | $11M | $12M | $10M | $12M | $14M | $12M | $13M | $9M | $10M | |
| Cost of Revenue | $5M | $5M | $7M | $5M | $4M | $4M | $5M | $5M | $5M | $4M | $4M | $4M | $5M | $4M | $3M | $3M | |
| Gross Profit | $9M | $8M | $12M | $8M | $7M | $6M | $9M | $7M | $7M | $6M | $8M | $9M | $8M | $8M | $6M | $7M | |
| R&D Expense | $793.0K | $765.0K | $944.0K | $801.0K | $824.0K | $804.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| SG&A Expense | $5M | $4M | $5M | $4M | $4M | $3M | $5M | $4M | $5M | $5M | $5M | $5M | $5M | $6M | $5M | $5M | |
| Operating Expenses | $11M | $9M | $12M | $9M | $10M | $9M | $12M | $11M | $13M | $13M | $13M | $13M | $13M | $14M | $12M | $13M | |
| Operating Income | $-2M | $-911.0K | $11.0K | $-832.0K | $-3M | $-3M | $-3M | $-4M | $-6M | $-7M | $-5M | $-1M | $-6M | $-6M | $-6M | $-6M | |
| Interest Expense | · | · | · | · | · | · | · | · | $1M | $1M | $585.0K | $543.0K | $234.0K | $3.0K | $1.0K | $3.0K | |
| Interest Income | $250.0K | $244.0K | $234.0K | $292.0K | $278.0K | $304.0K | $294.0K | $378.0K | $439.0K | $495.0K | $248.0K | $179.0K | $51.0K | $64.0K | $73.0K | $18.0K | |
| Other Non-op | $-1M | $-1M | $-3M | $-1M | $-1M | $-1M | $-3M | $-1M | $-1.0K | $-21.0K | $-19.0K | $282.0K | $-188.0K | $19.0K | $37.0K | $622.0K | |
| Pretax Income | $-3M | $-2M | $-1M | $-2M | $-4M | $-4M | $-5M | $-5M | $-7M | $-8M | $-5M | $-953.0K | $-6M | $-6M | $-6M | $-5M | |
| Income Tax | $124.0K | $143.0K | $94.0K | $78.0K | $49.0K | $49.0K | $89.0K | $60.0K | $50.0K | $53.0K | $-318.0K | $66.0K | $-2M | $151.0K | $50.0K | $96.0K | |
| Net Income | $-3M | $-2M | $-1M | $-2M | $-4M | $-4M | $-5M | $-5M | $-7M | $-8M | $-5M | $-994.0K | $-3M | $-6M | $-6M | $-5M | |
| EPS (Basic) | $-0.07 | $-0.05 | $-0.03 | $-0.05 | $-0.09 | $-0.10 | $-0.11 | $-0.14 | $-0.19 | $-0.22 | $-0.13 | $-0.03 | $-0.10 | $-0.17 | $-0.17 | $-0.16 | |
| EPS (Diluted) | · | · | · | · | · | · | · | · | $-0.19 | $-0.22 | $-0.13 | $-0.03 | $-0.10 | $-0.17 | $-0.17 | $-0.16 | |
| Shares (Basic) | 43,850,000 | 43,742,000 | · | 40,748,000 | 40,729,000 | 40,729,000 | · | 34,644,000 | 34,644,000 | 34,644,000 | 34,642,000 | 34,603,000 | 34,598,000 | · | 34,569,000 | 34,464,000 | |
| Shares (Diluted) | · | · | · | · | · | · | · | · | 34,644,000 | 34,644,000 | 34,642,000 | 34,603,000 | 34,598,000 | · | 34,569,000 | 34,464,000 | |
| EBITDA | $-2M | $-709.0K | · | $-832.0K | $-3M | $-3M | · | $-4M | $-6M | $-6M | $-5M | $-1M | $-5M | · | $-6M | $-6M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $28M | $31M | $32M | $25M | $29M | $31M | $32M | $28M | $33M | $37M | $22M | $18M | $16M | $10M | $15M | $20M | |
| Receivables | $14M | $13M | $17M | $13M | $11M | $12M | $15M | $13M | $13M | $12M | $13M | $12M | $10M | $11M | $9M | $10M | |
| Inventory | $11M | $10M | $9M | $9M | $8M | $8M | $8M | $9M | $9M | $10M | $11M | $11M | $11M | $12M | $12M | $10M | |
| Prepaid Expense | $1M | $1M | $1M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Current Assets | $53M | $55M | $58M | $49M | $50M | $52M | $56M | $52M | $57M | $62M | $50M | $53M | $53M | $43M | $46M | $51M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $7M | $7M | $7M | |
| PP&E (Gross) | · | · | $7M | · | · | · | $5M | · | · | · | $5M | $5M | $5M | $11M | · | · | |
| Accum. Depreciation | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $4M | $3M | $5M | $5M | $5M | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | |
| Total Assets | $61M | $63M | $67M | $57M | $58M | $60M | $65M | $61M | $65M | $71M | $59M | $62M | $57M | $52M | $55M | $59M | |
| Accounts Payable | $2M | $3M | $3M | $3M | $3M | $2M | $3M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $2M | $3M | |
| Accrued Liabilities | $7M | $6M | $8M | $7M | $7M | $7M | $8M | $7M | · | · | · | · | · | · | · | · | |
| Current Liabilities | $9M | $9M | $12M | $11M | $11M | $10M | $11M | $10M | $11M | $11M | $10M | $19M | $19M | $12M | $11M | $11M | |
| Capital Leases | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $448.0K | $470.0K | $454.0K | $514.0K | |
| Other Non-current Liabilities | $336.0K | $339.0K | $347.0K | $293.0K | $292.0K | $270.0K | $259.0K | $201.0K | $192.0K | $194.0K | $181.0K | $185.0K | $185.0K | $181.0K | $133.0K | $142.0K | |
| Total Liabilities | $50M | $50M | $52M | $51M | $51M | $50M | $51M | $50M | $50M | $50M | $26M | $26M | $21M | $14M | $13M | $13M | |
| Long-term Debt | $38M | $38M | $38M | $38M | $38M | $38M | · | $38M | · | · | · | $9M | $9M | · | · | · | |
| Total Debt | $35M | $35M | · | $35M | $34M | $34M | · | $34M | $34M | $33M | $9M | $9M | $9M | · | · | · | |
| Common Stock | $42.0K | $42.0K | $42.0K | $38.0K | $38.0K | $38.0K | $38.0K | $35.0K | $35.0K | $35.0K | $35.0K | $35.0K | $35.0K | $35.0K | $35.0K | $34.0K | |
| Paid-in Capital | $105M | $104M | $104M | $94M | $93M | $93M | $92M | $84M | $83M | $82M | $78M | $77M | $75M | $73M | $72M | $70M | |
| Retained Earnings | $-94M | $-91M | $-89M | $-88M | $-86M | $-82M | $-78M | $-73M | $-69M | $-62M | $-45M | $-40M | $-39M | $-36M | $-30M | $-24M | |
| Stockholders' Equity | $11M | $13M | $15M | $6M | $7M | $11M | $14M | $11M | $15M | $20M | $33M | $37M | $36M | $38M | $42M | $46M | |
| Liabilities + Equity | $61M | $63M | $67M | $57M | $58M | $60M | $65M | $61M | $65M | $71M | $59M | $62M | $57M | $52M | $55M | $59M | |
| Shares Outstanding | 42,116,330 | 41,868,436 | 41,785,946 | 37,819,478 | 37,793,886 | 37,793,886 | 37,793,886 | 34,643,926 | 34,643,926 | 34,643,926 | 34,643,855 | 34,628,517 | 34,597,822 | 34,597,822 | 34,588,398 | 34,493,085 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $196.0K | $202.0K | $221.0K | $164.0K | $132.0K | $138.0K | $142.0K | $144.0K | $156.0K | $157.0K | $186.0K | $151.0K | $203.0K | $202.0K | $216.0K | $247.0K | |
| Stock-based Comp | $1M | $312.0K | $500.0K | $530.0K | $520.0K | $451.0K | $838.0K | $997.0K | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | |
| Restructuring | · | · | · | · | · | · | $600.0K | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $1M | · | · | · | $3M | · | · | · | $-50.0K | · | · | $32.0K | · | · | · | |
| Operating Cash Flow | $-3M | $-572.0K | $-3M | $-4M | $-1M | $-702.0K | $-3M | $-4M | $-4M | $-6M | $4M | $-5M | $-2M | $-5M | $-5M | $-6M | |
| CapEx | $66.0K | $60.0K | $275.0K | $519.0K | $265.0K | $55.0K | $245.0K | $153.0K | $289.0K | $35.0K | $174.0K | $156.0K | $110.0K | $142.0K | $188.0K | $401.0K | |
| Investing Cash Flow | $-66.0K | $-60.0K | $-275.0K | $-519.0K | $-265.0K | $-55.0K | $-245.0K | $-153.0K | $-289.0K | $-35.0K | $-174.0K | $7M | $-110.0K | $-142.0K | $-188.0K | $-401.0K | |
| Debt Issued | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $9M | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | $9M | · | · | · | |
| Financing Cash Flow | $-5.0K | $83.0K | $9M | $45.0K | $25.0K | $25.0K | $7M | $-5.0K | $-5.0K | $-5.0K | $164.0K | $46.0K | $8M | $-10.0K | $127.0K | $2.0K | |
| Net Change in Cash | $-4M | $-603.0K | $7M | $-4M | $-2M | $-730.0K | $4M | $-5M | $-5M | $-6M | $4M | $2M | $6M | $-5M | $-5M | $-6M | |
| Taxes Paid | $166.0K | $0 | $178.0K | $4.0K | $75.0K | $1.0K | $171.0K | $31.0K | $174.0K | $6.0K | · | · | · | · | · | · | |
| Free Cash Flow | · | $-632.0K | · | · | · | $-757.0K | · | · | · | $-6M | · | · | $-2M | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-8M | · | · | $-2M | · | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 63.9% | 63.4% | · | 64.4% | 62.3% | 60.1% | · | 60.5% | 61.7% | 58.1% | 66.6% | 68.4% | 62.4% | · | 63.2% | 67.2% | |
| Operating Margin | -13.0% | -7.3% | · | -6.5% | -22.6% | -32.4% | · | -31.6% | -45.7% | -64.6% | -38.7% | -9.1% | -46.2% | · | -63.4% | -58.1% | |
| Net Margin | -23.4% | -16.9% | · | -15.4% | -33.2% | -44.0% | · | -40.9% | -54.0% | -74.0% | -38.6% | -7.3% | -28.7% | · | -63.2% | -52.7% | |
| Pretax Margin | -21.2% | -16.0% | · | -14.6% | -32.4% | -43.7% | · | -40.6% | -53.8% | -73.6% | -41.7% | -7.0% | -47.8% | · | -63.0% | -52.0% | |
| EBITDA Margin | -13.0% | -5.7% | · | -6.5% | -22.6% | -30.9% | · | -31.6% | -45.7% | -63.0% | -38.7% | -9.1% | -44.5% | · | -63.4% | -58.1% | |
| ROA | -5.4% | -3.4% | · | -3.4% | -6.1% | -6.3% | · | -7.8% | -10.3% | -11.9% | -8.1% | -1.6% | -5.8% | · | -9.4% | -8.4% | |
| ROE | -36.2% | -18.1% | · | -23.5% | -34.4% | -27.0% | · | -21.2% | -25.5% | -26.9% | -12.3% | -2.4% | -8.1% | · | -12.0% | -10.5% | |
| ROIC | -4.1% | -2.0% | · | -2.1% | -6.3% | -6.9% | · | -8.2% | -11.6% | -12.4% | -10.2% | -2.9% | -7.6% | · | -13.9% | -13.2% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 5.8 | · | 4.4 | 4.7 | 5.5 | · | 5.5 | 5.3 | 5.9 | 4.9 | 2.8 | 2.8 | · | 4.1 | 4.5 | |
| Quick Ratio | 4.4 | 4.6 | · | 3.5 | 3.8 | 4.5 | · | 4.3 | 4.3 | 4.7 | 3.4 | 1.6 | 1.4 | · | 2.1 | 2.7 | |
| Debt / Equity | 3.3 | 2.7 | · | 5.9 | 4.7 | 3.2 | · | 3.1 | 2.3 | 1.6 | 0.3 | 0.2 | 0.2 | · | · | · | |
| LT Debt / Equity | 3.3 | 2.7 | · | 5.9 | 4.7 | 3.2 | · | 3.1 | 2.3 | 1.6 | 0.3 | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -3.9 | -4.7 | -7.9 | -2.3 | -24.0 | · | -5782.0 | -1992.0 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.2 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.4 | · | 0.4 | 0.5 | 0.4 | 0.3 | 0.4 | 0.5 | · | 0.4 | 0.5 | |
| Receivables Turnover | 1.1 | 1.0 | · | 1.0 | 0.9 | 0.8 | · | 0.9 | 1.0 | 0.9 | 1.1 | 1.2 | 1.1 | · | 0.9 | 1.1 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.25 | $0.31 | · | $0.15 | $0.19 | $0.28 | · | $0.32 | $0.43 | $0.58 | $0.96 | $1.06 | $1.04 | · | $1.21 | $1.33 | |
| Revenue / Share | · | · | · | · | · | · | · | · | $0.35 | $0.30 | $0.35 | $0.39 | $0.35 | · | $0.26 | $0.30 | |
| Cash Flow / Share | · | · | · | · | · | · | · | · | · | $-0.18 | · | · | $-0.05 | · | · | · | |
| Cash / Share | $0.66 | $0.74 | · | $0.66 | $0.78 | $0.82 | · | $0.81 | $0.94 | $1.08 | $0.64 | $0.53 | $0.47 | · | $0.43 | $0.58 | |
| EPS (TTM) | · | · | · | · | · | · | · | · | · | · | $-0.43 | $-0.47 | $-0.60 | · | $-0.56 | $-0.51 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $58M | $56M | · | $48M | $47M | $47M | · | · | · | · | $50M | $47M | $44M | · | $49M | $51M | |
| Net Income TTM | $-9M | $-9M | · | $-15M | $-17M | $-20M | · | · | · | · | $-15M | $-16M | $-21M | · | $-19M | $-18M | |
| Market Cap | $189M | $154M | · | $81M | $85M | $52M | · | $43M | $46M | $47M | $111M | $174M | $100M | · | $155M | $202M | |
| Enterprise Value | $197M | $158M | · | $90M | $90M | $55M | · | $49M | $47M | $43M | $98M | $165M | $92M | · | · | · | |
| P/E | · | · | · | · | · | · | · | · | · | · | -7.4 | -10.7 | -4.8 | · | -8.0 | -11.5 | |
| P/S | 3.2 | 2.8 | · | 1.7 | 1.8 | 1.1 | · | · | · | · | 2.2 | 3.7 | 2.3 | · | 3.2 | 3.9 | |
| P/B | 17.7 | 12.0 | · | 13.8 | 11.7 | 4.9 | · | 3.9 | 3.1 | 2.3 | 3.3 | 4.8 | 2.8 | · | 3.7 | 4.4 | |
| P / Tangible Book | 17.7 | 12.0 | · | 13.8 | 11.7 | 4.9 | · | 3.9 | 3.1 | 2.3 | 3.3 | 4.8 | 2.8 | · | 3.7 | 4.4 | |
| P / Cash Flow | · | -270.1 | · | · | · | -73.8 | · | · | · | -7.4 | · | · | -53.0 | · | · | · | |
| EV / Revenue | 3.4 | 2.8 | · | 1.9 | 1.9 | 1.2 | · | · | · | · | 1.9 | 3.5 | 2.1 | · | · | · | |
| Earnings Yield | · | · | · | · | · | · | · | · | · | · | -13.4% | -9.3% | -20.8% | · | -12.5% | -8.7% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $53M | $48M | $52M | $45M | $49M |
| Bruttogewinnmarge % | 62.5% | 61.0% | 64.5% | 65.5% | 69.3% |
| Betriebsgewinnmarge % | -12.2% | -39.2% | -33.0% | -52.9% | -29.8% |
| Nettoergebnis | $-11M | $-23M | $-19M | $-23M | $-15M |
| Verwässerte EPS | · | · | $-0.54 | $-0.67 | $-0.44 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 2.4 | 2.4 | 1.2 | · | · |
| Liquiditätsgrad | 5.0 | 5.3 | 5.5 | 3.6 | 4.6 |
| Quick Ratio | 4.1 | 4.4 | 4.5 | 1.8 | 3.3 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-9M | $-19M | $-6M | $-21M | $-11M |
Institutionelle Eigentümer (13F) 68 Einreicher · $99.4M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
68
Gehaltener Wert
$99.4M
Neue Positionen
10
Geschlossene Positionen
10
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 10 (-5 vs. Vorquartal) | 10 (+5 vs. Vorquartal) | 21 (-3 vs. Vorquartal) | 24 (+8 vs. Vorquartal) | +386K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| ROYCE & ASSOCIATES LP | $14.700.547 | 3.274.064 | 14,78% | Aktien |
| Nantahala Capital Management, LLC | $14.683.414 | 3.270.248 | 14,77% | Aktien |
| Archon Capital Management LLC | $11.874.779 | 2.644.717 | 11,94% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $6.891.463 | 1.534.847 | 6,93% | Aktien |
| VANGUARD GROUP INC | $5.477.774 | 1.565.078 | 5,51% | Aktien |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $5.103.469 | 1.136.630 | 5,13% | Aktien |
| AIGH Capital Management LLC | $5.066.260 | 1.128.343 | 5,09% | Aktien |
| Silverberg Bernstein Capital Management LLC | $4.667.988 | 1.039.641 | 4,69% | Aktien |
| COMMONWEALTH EQUITY SERVICES, LLC | $2.914.280 | 649.061 | 2,93% | Aktien |
| HORIZON KINETICS ASSET MANAGEMENT LLC | $2.626.650 | 585.000 | 2,64% | Aktien |
| BlackRock, Inc. | $2.518.828 | 560.986 | 2,53% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $2.488.708 | 554.278 | 2,50% | Aktien |
| Taylor Frigon Capital Management LLC | $1.857.073 | 413.602 | 1,87% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $1.799.895 | 400.600 | 1,81% | Aktien |
| SEI INVESTMENTS CO | $1.261.820 | 281.029 | 1,27% | Aktien |
| Huntleigh Advisors, Inc. | $1.181.906 | 263.231 | 1,19% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $1.089.557 | 242.663 | 1,10% | Aktien |
| MARSHALL WACE, LLP | $1.061.732 | 236.466 | 1,07% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.005.854 | 224.021 | 1,01% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $971.021 | 216.263 | 0,98% | Aktien |
| Kingsview Wealth Management, LLC | $962.153 | 214.288 | 0,97% | Aktien |
| Caption Management, LLC | $821.683 | 183.003 | 0,83% | Aktien |
| Hillsdale Investment Management Inc. | $819.874 | 182.600 | 0,82% | Aktien |
| Informed Momentum Co LLC | $765.410 | 170.470 | 0,77% | Aktien |
| CITADEL ADVISORS LLC | $755.864 | 168.344 | 0,76% | Aktien |
| STATE STREET CORP | $539.725 | 120.206 | 0,54% | Aktien |
| NewEdge Advisors, LLC | $430.208 | 95.815 | 0,43% | Aktien |
| Z3 Capital Partners, LLC | $409.079 | 91.109 | 0,41% | Aktien |
| JANE STREET GROUP, LLC | $407.562 | 90.771 | 0,41% | Aktien |
| Caption Management, LLC | $373.119 | 83.100 | 0,38% | Kaufoption |
| NORTHERN TRUST CORP | $352.766 | 78.567 | 0,35% | Aktien |
| RPg Family Wealth Advisory, LLC | $342.362 | 76.250 | 0,34% | Aktien |
| Kanen Wealth Management LLC | $336.301 | 74.900 | 0,34% | Aktien |
| Centiva Capital, LP | $285.357 | 63.554 | 0,29% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $276.588 | 61.601 | 0,28% | Aktien |
| GOLDMAN SACHS GROUP INC | $199.302 | 44.388 | 0,20% | Aktien |
| PERKINS CAPITAL MANAGEMENT INC | $188.580 | 42.000 | 0,19% | Aktien |
| MORGAN STANLEY | $185.603 | 41.337 | 0,19% | Aktien |
| Squarepoint Ops LLC | $144.327 | 32.144 | 0,15% | Aktien |
| XTX Topco Ltd | $136.227 | 30.340 | 0,14% | Aktien |
| Dauntless Investment Group, LLC | $135.818 | 30.249 | 0,14% | Aktien |
| Point72 Asset Management, L.P. | $118.312 | 26.350 | 0,12% | Aktien |
| Jefferies Financial Group Inc. | $110.005 | 24.500 | 0,11% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $100.985 | 22.491 | 0,10% | Aktien |
| FRANKLIN RESOURCES INC | $98.928 | 22.033 | 0,10% | Aktien |
| Creative Planning | $98.331 | 21.900 | 0,10% | Aktien |
| Joel Isaacson & Co., LLC | $92.045 | 20.500 | 0,09% | Aktien |
| CITIGROUP INC | $85.261 | 18.989 | 0,09% | Aktien |
| AXQ CAPITAL, LP | $77.713 | 17.308 | 0,08% | Aktien |
| NWAM LLC | $77.403 | 17.239 | 0,08% | Aktien |
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Stavros G. Vizirgianakis ×2 Einreichungen | 9. Mai 2024 | · | Erste Einreichung | · | SEC |
| Strategos Fund, L.P., Strategos Master Fund, L.P., Strategos Master Fund GP LLC, Archon Capital Management LLC, Constantinos Christofilis | 5. April 2024 | · | Erste Einreichung | Passive Anlage | SEC |
| Great Point Partners, LLC, Dr. Jeffrey R. Jay, M.D., Mr. David Kroin ×3 Einreichungen | 23. November 2016 | · | Erste Einreichung | Passive Anlage | SEC |
| ACMI Corporation (f/k/a Circon Corporation, “ACMI”), American Cystoscope Makers, Inc. (f/k/a Circon Holdings Corporation, “Holdings”), Fox Paine Capital Fund, L.P. (“FPCF”), Fox Paine & Company, LLC (“Fox Paine”), Fox Paine Capital, LLC (“FPC”) ×2 Einreichungen | 1. Oktober 2004 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 1. Juni 2004 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 34 Insider · 10 Führungskräfte · 17 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Charles D. Goodwin II | Chief Executive Officer | 11. Juni 2026 A | 90.000 | 0 | 0 | $0 |
| Robert Gershon | Chief Executive Officer | 1. Mai 2017 A | 30.000 | 0 | 0 | $0 |
| Matthew C Hill | Chief Financial Officer | 11. Juni 2026 A | 8.500 | 0 | 0 | $0 |
| Tara Semb | Chief Financial Officer | 11. Januar 2023 A | · | 0 | 0 | $0 |
| Gary Pickett | Chief Financial Officer | 12. Juli 2012 A | · | 0 | 0 | $0 |
| Robert J Saron | President | 1. Mai 2017 A | 393.698 | 0 | 0 | $0 |
| Shawn David Roman | Chief Operating Officer | 15. Juni 2026 M | 16.467 | 0 | 0 | $0 |
| Moshe Citronowicz | Sr. V.P. of Operations | 11. Juni 2026 A | 493.504 | 0 | 0 | $0 |
| Todd Hornsby | Executive Vice President | 10. Januar 2024 A | 0 | 0 | 0 | $0 |
| John J. Mccarthy III | Chief CommercializationOfficer | 1. Mai 2017 A | 115.750 | 0 | 0 | $0 |
| Lawrence Waldman | Direktor | 30. Juni 2026 M | 12.314 | 0 | 0 | $0 |
| Wendy Lauren Levine | Direktor | 11. Juni 2026 A | · | 0 | 0 | $0 |
| Minnie Baylor-Henry | Direktor | 11. Juni 2026 A | · | 0 | 0 | $0 |
| Stavros G. Vizirgianakis | Direktor | 11. Juni 2026 A | 2.196.191 | 0 | 0 | $0 |
| Craig A. Swandal | Direktor | 8. August 2024 A | 60.173 | 0 | 0 | $0 |
| John C. Andres | Direktor | 8. August 2024 A | · | 0 | 0 | $0 |
| Michael Geraghty | Direktor | 8. August 2024 A | 27.500 | 0 | 0 | $0 |
| Andrew Makrides | Direktor | 10. August 2023 A | 624.389 | 0 | 0 | $0 |
| Charles T. Orsatti | Direktor | 28. Juli 2016 A | · | 0 | 0 | $0 |
| August Lentricchia | Direktor | 9. Dezember 2013 A | · | 0 | 0 | $0 |
| Gregory Alan Konesky | Direktor | 23. Dezember 2011 S | 1.750 | 0 | 0 | $0 |
| RENN Universal Growth Investment Trust | Direktor | 25. August 2011 P | 1.247.800 | 0 | 0 | $0 |
| Pardoll Peter | Direktor | 2. Dezember 2010 S | 2.500 | 0 | 0 | $0 |
| Steven Maclaren | Direktor | 8. Juli 2010 A | · | 0 | 0 | $0 |
| ACMI CORP | 10%-Eigentümer | 24. September 2004 P | 0 | 0 | 0 | $0 |
| MEDICAL WIND DOWN HOLDINGS I INC | 10%-Eigentümer | 21. Mai 2004 J | 0 | 0 | 0 | $0 |
| Jay D. Ewers | · | 4. Januar 2018 A | · | 0 | 0 | $0 |
| Michael G Norman | · | 9. Dezember 2013 A | · | 0 | 0 | $0 |
| George W Kromer | · | 1. Oktober 2013 G | 247.508 | 0 | 0 | $0 |
| Leonard Keen | · | 8. Juli 2010 A | · | 0 | 0 | $0 |
| Brian Madden | · | 26. Oktober 2009 A | 7.500 | 0 | 0 | $0 |
| Randy D Rossi | · | 12. Juni 2008 M | 35.000 | 0 | 0 | $0 |
| Charles Peabody | · | 2. Dezember 2005 S | 0 | 0 | 0 | $0 |
| Alfred V Greco | · | 5. Mai 2005 A | 19.500 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 4 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
APYX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 11 Analysten
KAUF
Median-Ziel
$6.00
+135,3%
3 27,3%
Starker Kauf
7 63,6%
Kauf
1 9,1%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
5 Analysten · 2026-09-20Mittelwert-Ziel $6.60 +158,8%
← Unter allen Zielen
Aktueller Preis $2.55
Tief$6.00
Mittelwert$6.60
Hoch$8.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| APYX | $146M | -6.1 | 9.9% | -21.2% | -78.0% | 62.5% |
| AGPU | $29M | · | 47.7% | -186053.5% | -1012.1% | · |
| KRMD | $269M | -96.8 | 22.2% | -6.4% | -15.7% | 62.3% |
| LUCD | $143M | -1.1 | 8.3% | -1232.7% | -617.2% | · |
| VANI | $94M | -2.9 | · | · | -257.8% | · |
| KEQU | $106M | 11.5 | 17.3% | 3.4% | 13.3% | 28.5% |
| ECOR | $36M | -2.7 | 27.2% | -43.6% | 4686.6% | 86.8% |
| HYPR | · | -2.3 | 5.2% | -262.3% | -93.5% | 49.8% |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026